Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention

Trial ID or NCT#

NCT04096781

Status

not recruiting iconNOT RECRUITING

Purpose

A multi-center, randomized controlled 2-arm trial comparing the effectiveness of an innovative shared decision-making pathway and usual care for Atrial Fibrillation Stroke Prevention

Official Title

Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - ≥ 18 y/o - Non-valvular atrial fibrillation or atrial flutter (AFib) - CHA2DS2-VASc stroke score of: - Men: 1 or more - Women: 2 or more - Able to consent in English or Spanish (if resources allow) and follow study instructions
Exclusion Criteria:
  1. - Moderate to severe mitral stenosis - Mechanical valve replacement - Absolute contraindication to anticoagulation (Based on clinician judgment) - Indication for anticoagulation therapy for a condition other than atrial fibrillation - Left atrial appendage exclusion (by surgery or device placement) - At the clinical discretion of the investigator

Investigator(s)

Paul  J. Wang, MD
Paul J. Wang, MD
Cardiac electrophysiologist
John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering
Randall Stafford
Randall Stafford
Professor of Medicine (Stanford Center for Research in Disease Prevention)
Bryant Lin
Bryant Lin
Internal medicine doctor
Clinical Professor, Medicine - Primary Care and Population Health

Contact us to find out if this trial is right for you.

Contact

Katie DeSutter
650-725-4151